Abstract | BACKGROUND: METHODS: Eleven patients scheduled for transurethral resection of bladder tumors under general anesthesia were investigated. After general anesthesia induction, neuromuscular monitoring of the adductor pollicis muscle and ultrasonography-guided stimulation of the obturator nerve was commenced. Rocuronium, 0.15 mg/kg, was repeatedly administered intravenously. The adequate rocuronium dose required for complete block of the thigh muscles, defined as the cumulative dose of rocuronium administered until that time, and its correlation with the first twitch response of the adductor pollicis muscle on train-of-four stimulation after initial rocuronium administration was analyzed. RESULTS: The rocuronium dose found adequate for complete block of the thigh muscles was 0.30 mg/kg in seven patients and 0.45 mg/kg in the remaining four patients, which did not correlate with the first twitch response. At the time of complete block of the thigh muscles, the neuromuscular blockade level of the adductor pollicis muscle varied greatly, although the level was never more profound than a post-tetanic count of 1. CONCLUSION: Although the response of the adductor pollicis muscle to rocuronium cannot be used to determine the adequate rocuronium dose required for complete block of the thigh muscles, intense blockade, with maintenance of post-tetanic count at ≤ 1 in the adductor pollicis muscle is essential to prevent the obturator jerk.
|
Authors | M Fujimoto, K Kawano, T Yamamoto |
Journal | Acta anaesthesiologica Scandinavica
(Acta Anaesthesiol Scand)
Vol. 62
Issue 3
Pg. 304-311
(Mar 2018)
ISSN: 1399-6576 [Electronic] England |
PMID | 29178460
(Publication Type: Journal Article, Observational Study)
|
Copyright | © 2017 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd. |
Chemical References |
- Neuromuscular Nondepolarizing Agents
- Rocuronium
|
Topics |
- Aged
- Aged, 80 and over
- Female
- Humans
- Male
- Middle Aged
- Neuromuscular Blockade
- Neuromuscular Nondepolarizing Agents
(administration & dosage)
- Prospective Studies
- Rocuronium
(administration & dosage)
- Thigh
- Urinary Bladder Neoplasms
(surgery)
|